ME has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ME has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. 23andMe Holding Co's Marketable Securities for the quarter that ended in Sep. 2024 was $0.0 Mil.
The historical data trend for 23andMe Holding Co's Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
23andMe Holding Co Annual Data | |||||||||||
Trend | Mar20 | Mar21 | Mar22 | Mar23 | Mar24 | ||||||
Marketable Securities | - | - | - | - | - |
23andMe Holding Co Quarterly Data | |||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Marketable Securities | Get a 7-Day Free Trial | - | - | - | - | - |
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.
23andMe Holding Co (NAS:ME) Marketable Securities Explanation
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
Thank you for viewing the detailed overview of 23andMe Holding Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.
Kathy L Hibbs | officer: See Remarks | C/O VIROLOGIC, 345 OYSTER POINT BLVD, SOUTH SAN FRANCISCO CA 94080 |
William G Richards | officer: Head of Therapeutics Discovery | 160 KELLY AVE, HALF MOON BAY CA 94019 |
Richard H Scheller | director | C/O GENENTECH INC, 1 DNA WAY MS 49, SOUTH SAN FRANCISCO CA 94080-4990 |
Joseph Anthony Selsavage | officer: Interim CFO | 490 HILL STREET, APT 5, SAN FRANCISCO CA 94114 |
Kenneth J. Hillan | officer: Head of Therapeutics | C/O ACHAOGEN, INC., 7000 SHORELINE COURT, SUITE 371, SOUTH SAN FRANCISCO CA 94080 |
Evan Lovell | director, officer: Chief Financial Officer | 27 SOUTH PARK STREET, SUITE 200, SAN FRANCISCO CA 94107 |
Hernandez Sandra R Md | director | BLACKBAUD INC, 2000 DANIEL ISLAND DRIVE, CHARLESTON SC 29492 |
Paul D Johnson | officer: VP, General Manager-Consumer | 440 N BARRANCA AVE #3550, COVINA CA 91723 |
Tracy Keim | officer: See Remarks | 6107 ARROWROOT LANE, RANCHO PALOS VERDES CA 90275 |
Steven Lemon | officer: Vice President, Engineering | 1020 CHERRY AVENUE, SAN JOSE CA 95125 |
Steven J Schoch | officer: See Remarks | 2748 BUSH STREET, SAN FRANCISCO CA 94115 |
Frederick Mark Kohler | officer: Vice President, People | 1004 UNION STREET, ALAMEDA CA 94501 |
Sequoia Capital Global Growth Ii Principals Fund, L.p. | 10 percent owner | 2800 SAND HILL ROAD, SUITE 101, MENLO PARK CA 94025 |
Abeec 2.0, Llc | 10 percent owner | 171 MAIN STREET, SUITE 259, LOS ALTOS CA 94022 |
Anne Wojcicki | director, 10 percent owner, officer: Chief Executive Officer | C/O AJAX I HOLDINGS, LLC, 667 MADISON AVENUE, NEW YORK NY 10606 |
From GuruFocus
By Marketwired • 10-01-2024
By Marketwired • 09-27-2024
By GuruFocus News • 10-09-2024
By Marketwired • 09-19-2024
By Marketwired • 10-08-2024
By GuruFocus News • 10-22-2024
By Marketwired • 09-25-2024
By GuruFocus News • 11-13-2024
By Marketwired • 10-17-2024
By Marketwired • 11-07-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.